BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 23663682)

  • 1. Incidence of granulomatosis with polyangiitis (Wegener's) in Greenland and the Faroe Islands: epidemiology of an ANCA-associated vasculitic syndrome in two ethnically distinct populations in the North Atlantic area.
    Faurschou M; Helleberg M; Obel N; Baslund B
    Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S52-5. PubMed ID: 23663682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are anti-proteinase-3 ANCA a useful marker of granulomatosis with polyangiitis (Wegener's) relapses? Results of a retrospective study on 126 patients.
    Thai LH; Charles P; Resche-Rigon M; Desseaux K; Guillevin L
    Autoimmun Rev; 2014 Mar; 13(3):313-8. PubMed ID: 24225075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center.
    Schirmer JH; Wright MN; Herrmann K; Laudien M; Nölle B; Reinhold-Keller E; Bremer JP; Moosig F; Holle JU
    Arthritis Rheumatol; 2016 Dec; 68(12):2953-2963. PubMed ID: 27333332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets.
    Miloslavsky EM; Lu N; Unizony S; Choi HK; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Fervenza F; Monach PA; Specks U; Stone JH
    Arthritis Rheumatol; 2016 Dec; 68(12):2945-2952. PubMed ID: 27428559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in proteinase 3 anti-neutrophil cytoplasm autoantibody levels in early systemic granulomatosis with polyangiitis (Wegener's) may reflect treatment rather than disease activity.
    Rasmussen N; Salmela A; Ekstrand A; de Groot K; Gregorini G; Cohen Tervaert JW; Gross WL; Wiik A; Jayne DR;
    Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S38-44. PubMed ID: 23380137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of interleukin-32 and interleukin-6 in granulomatosis with polyangiitis and microscopic polyangiitis: association with clinical and biochemical findings.
    Krajewska Wojciechowska J; Kościelska-Kasprzak K; Krajewski W; Morawski K
    Eur Cytokine Netw; 2019 Dec; 30(4):151-159. PubMed ID: 32096477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Epidemiology of Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis in Olmsted County, Minnesota: A Twenty-Year US Population-Based Study.
    Berti A; Cornec D; Crowson CS; Specks U; Matteson EL
    Arthritis Rheumatol; 2017 Dec; 69(12):2338-2350. PubMed ID: 28881446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overlap of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.
    Surendran S; Gundappa C; Gandhi A; Kurien AA; Fernando E
    Saudi J Kidney Dis Transpl; 2017; 28(3):639-644. PubMed ID: 28540906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is granulomatosis with polyangiitis in Asia different from the West?
    Naidu GSRSNK; Misra DP; Rathi M; Sharma A
    Int J Rheum Dis; 2019 Jan; 22 Suppl 1():90-94. PubMed ID: 30338654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinicopathologic characteristics of granulomatosis with polyangiitis (Wegener's): a retrospective study of 45 patients in Korea.
    Kim HW; Kim JW; Im CH; Shin KC; Lee EY; Lee EB; Song YW
    Mod Rheumatol; 2013 Sep; 23(5):864-71. PubMed ID: 22983617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wegener's Granulomatosis Presenting as Wallenberg Syndrome: A Case Report.
    Emamikhah M; Sina F; Mokhtari M; Shirani F; Asadipanah M
    J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):e107-e109. PubMed ID: 31027983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features of childhood granulomatosis with polyangiitis (wegener's granulomatosis).
    Bohm M; Gonzalez Fernandez MI; Ozen S; Pistorio A; Dolezalova P; Brogan P; Barbano G; Sengler C; Klein-Gitelman M; Quartier P; Fasth A; Herlin T; Terreri MT; Nielsen S; van Rossum MA; Avcin T; Castell ER; Foeldvari I; Foell D; Kondi A; Koné-Paut I; Kuester RM; Michels H; Wulffraat N; Amer HB; Malattia C; Martini A; Ruperto N
    Pediatr Rheumatol Online J; 2014; 12():18. PubMed ID: 24891844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical manifestations of granulomatosis with polyangiitis (Wegener's granulomatosis) in the upper respiratory tract seen by otolaryngologists in Japan.
    Harabuchi Y; Kishibe K; Komabayashi Y
    Clin Exp Nephrol; 2013 Oct; 17(5):663-666. PubMed ID: 23385778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of non-identified ANCA (non-PR3, non-MPO) in the diagnosis of granulomatosis with polyangiitis (Wegener's granulomatosis).
    Givaudan M; Vandergheynst F; Stordeur P; Ocmant A; Melot C; Gangji V; Soyfoo MS
    Acta Clin Belg; 2017 Oct; 72(5):313-317. PubMed ID: 28067125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing incidence and prevalence of ANCA-associated vasculitis in Northern Norway.
    Nilsen AT; Karlsen C; Bakland G; Watts R; Luqmani R; Koldingsnes W
    Rheumatology (Oxford); 2020 Sep; 59(9):2316-2324. PubMed ID: 31859355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Berti A; Warner R; Johnson K; Cornec D; Schroeder D; Kabat B; Langford CA; Hoffman GS; Fervenza FC; Kallenberg CGM; Seo P; Spiera R; St Clair EW; Brunetta P; Stone JH; Merkel PA; Specks U; Monach PA;
    Arthritis Rheumatol; 2018 Jul; 70(7):1114-1121. PubMed ID: 29693324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of granulomatosis with polyangiitis (Wegener's granulomatosis) in Northern Italy: a 15-year population-based study.
    Catanoso M; Macchioni P; Boiardi L; Manenti L; Tumiati B; Cavazza A; Luberto F; Pipitone N; Salvarani C
    Semin Arthritis Rheum; 2014 Oct; 44(2):202-7. PubMed ID: 24932888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG4:IgG RNA ratio differentiates active disease from remission in granulomatosis with polyangiitis: a new disease activity marker? A cross-sectional and longitudinal study.
    Al-Soudi A; Doorenspleet ME; Esveldt RE; Burgemeister LT; Hak AE; van den Born BJH; Tas SW; van Vollenhoven RF; Klarenbeek PL; de Vries N
    Arthritis Res Ther; 2019 Jan; 21(1):43. PubMed ID: 30704507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contrasting epidemiology of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis.
    Watts RA; Mooney J; Skinner J; Scott DG; Macgregor AJ
    Rheumatology (Oxford); 2012 May; 51(5):926-31. PubMed ID: 22258386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antineutrophil cytoplasmic antibodies in Wegener's granulomatosis.
    Wong SN; Shah V; Dillon MJ
    Arch Dis Child; 1998 Sep; 79(3):246-50. PubMed ID: 9875021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.